Jan Steffel
High Incidence of Inappropriate Alarms in Patients with Wearable Cardioverter-Defibrillators: Findings from the Swiss WCD Registry
Kovacs B, Schindler M, Haegeli L, Mayer K, Eriksson U, Herrera-Siklody C, Reichlin T, Steffel J, Saguner A, Kobza R, Dzemali O, Burri H, Buehler A, Reek S, Sticherling C, Schaer B, Linka A, Ammann P, Müller A, Duru F. High Incidence of Inappropriate Alarms in Patients with Wearable Cardioverter-Defibrillators: Findings from the Swiss WCD Registry. J Clin Med 2021; 10
25.08.2021High Incidence of Inappropriate Alarms in Patients with Wearable Cardioverter-Defibrillators: Findings from the Swiss WCD Registry
25.08.2021J Clin Med 2021; 10
Kovacs Boldizsar, Schindler Matthias, Haegeli Laurent, Mayer Kurt, Eriksson Urs, Herrera-Siklody Claudia, Reichlin Tobias, Steffel Jan, Saguner Ardan M, Kobza Richard, Dzemali Omer, Burri Haran, Buehler Andres, Reek Sven, Sticherling Christian, Schaer Beat, Linka Andre, Ammann Peter, Müller Andreas S, Duru Firat
Rapamycin promotes arterial thrombosis in vivo: implications for everolimus and zotarolimus eluting stents
Camici G, Steffel J, Amanovic I, Breitenstein A, Baldinger J, Keller S, Lüscher T, Tanner F. Rapamycin promotes arterial thrombosis in vivo: implications for everolimus and zotarolimus eluting stents. Eur Heart J 2009; 31:236-42.
29.06.2009Rapamycin promotes arterial thrombosis in vivo: implications for everolimus and zotarolimus eluting stents
29.06.2009Eur Heart J 2009; 31:236-42
Camici Giovanni G, Steffel Jan, Amanovic Ilijana, Breitenstein Alexander, Baldinger Jeannette, Keller Stephan, Lüscher Thomas F, Tanner Felix C
Dimethyl sulfoxide inhibits tissue factor expression, thrombus formation, and vascular smooth muscle cell activation: a potential treatment strategy for drug-eluting stents
Camici G, Lüscher T, Yang Z, Matter C, Shojaati K, Schulz U, Baldinger J, Schafer N, Akhmedov A, Steffel J, Tanner F. Dimethyl sulfoxide inhibits tissue factor expression, thrombus formation, and vascular smooth muscle cell activation: a potential treatment strategy for drug-eluting stents. Circulation 2006; 114:1512-21.
25.09.2006Dimethyl sulfoxide inhibits tissue factor expression, thrombus formation, and vascular smooth muscle cell activation: a potential treatment strategy for drug-eluting stents
25.09.2006Circulation 2006; 114:1512-21
Camici Giovanni G, Lüscher Thomas F, Yang Zhihong, Matter Christian M, Shojaati Kushiar, Schulz Urs, Baldinger Jeannette, Schafer Nicola, Akhmedov Alexander, Steffel Jan, Tanner Felix C